The future of biobanks looks promising with advancements in biotechnology and data analytics. Emerging technologies, such as artificial intelligence and machine learning, are expected to enhance the ability to analyze large datasets and uncover new insights. Additionally, international collaborations are likely to increase, leading to more comprehensive and diverse datasets, which will further enhance the potential of biobanks in advancing epidemiological research and public health.
